Table 3.
Number of antiretroviral drugs taken per day by 160 HIV/AIDS patients
| Drugs | Pills per day (n) | n(%) |
|---|---|---|
| Fixed-dose combination (AZT + 3TC + NVP) | 2 | 98 (61%) |
| Lose dose (AZT + 3TC + NVP) | 6 | 2 (1%) |
| Combined (AZT + 3TC) + EFV | 3 | 15 (9%) |
| Combined (FTC + TDF) + NVP | 3 | 5 (4%) |
| Combined (FTC + TDF) + EFV | 2 | 24 (15%) |
| Combined (FTC + TDF) + LPV/r | 5 | 2 (1%) |
| Combined (AZT + 3TC) + LPV/r | 6 | 12 (8%) |
| 3TC + ABC + NVP | 6 | 2 (1%) |
AZT indicates zidovudine; 3TC, lamivudine; NVP, nevirapine; EFV, efavirenz; FTC, emtricitabine; TDF, tenofovir; LPV, lopinavir; LPV/r, ritonavir-boosted lopinavir; ABC, abacavir.